Tenn. Comp. R. & Regs. 1200-07-02-.03 - DEFINITIONS

(1) "Cancer" means and includes, but is not limited to:
(a) a large group of diseases characterized by uncontrolled growth and spread of abnormal cells;
(b) any condition of tumors having the properties of anaplasia, invasion, and metastasis;
(c) a cellular tumor, the natural course of which is fatal;
(d) malignant neoplasm; and
(e) in-situ cancer.
(f) brain-related tumor.
(2) Brain-related tumor means a listed primary tumor (whether malignant or benign) occurring in any of the following sites:
(a) The brain, meninges, spinal cord, cauda equina, a cranial nerve or nerves, or any other part of the central nervous system.
(b) The pituitary gland, pineal gland or craniopharyngeal duct.
(3) "Commissioner" means the Commissioner of the Department of Health.
(4) "Data" shall mean the original information contained on the report required by the regulations, including, but not limited to, both identifying and non-identifying information.
(5) "Department" shall mean the Tennessee Department of Health, or "department," as used in the Act.
(6) "Facility" means a health care facility in which diagnosis or treatment services are provided to patients with cancer, including, but not limited to, an ambulatory surgical treatment center, a freestanding cancer treatment center, a radiation therapy center, a chemotherapy treatment center, a nursing home, an oncology or dermatology clinic, a laboratory, or any other facility which provides screening, detection, diagnostic or therapeutic services to patients with cancer.
(7) "Health care practitioner" means a physician, surgeon, or other health care professional licensed under T.C.A. Title 63 who is engaged in diagnosing and/or treating patients who have cancer.
(8) "Hospital" means an institution as defined by T.C.A.68-11-201.
(9) "Identifying information" means any information that could lead to the identification of a patient who has been diagnosed or treated for cancer.
(10) "In situ cancer" means an abnormality of the development and organization of cells without the invasion of neighboring tissue. Examples of in situ cancers include, but are not limited to:
(a) Cervical Intraepitheleal Neoplasia (CIN) II lesions; and
(b) Cervical Intraepitheleal Neoplasia (CIN) III lesions.
(11) "Laboratory" means a facility where tests are performed identifying anatomical and cytological changes, and where specimens are interpreted and pathological diagnoses are made.
(12) "Medical records" shall include, but not be limited to, pathology reports, cytology reports, radiology reports, and disease index for both inpatients and outpatients.
(13) "Person" means any member of the "medical, scientific, and academic research community."
(14) "Policies and Procedures Manual" means the document(s) maintained in the offices of the Tennessee Cancer Registry giving specific written instructions for the implementation of policies and procedures utilized by the Registry and which may be updated from time to time.
(15) "Tennessee Cancer Registry" or "Registry" or "TCR" shall mean the program in the Tennessee Department of Health that administers a population-based statewide cancer registry.

Notes

Tenn. Comp. R. & Regs. 1200-07-02-.03
Original rule filed October 6, 1986; effective November 20, 1986. Amendment filed September 5, 1990; effective October 20, 1990. Repeal and new rule filed February 1, 2002; effective April 17, 2002. Public necessity rule filed August 3, 2007; effective through January 15, 2008. Amendment filed August 28, 2007; effective December 28, 2007. Amendment filed August 25, 2009; effective November 23, 2009.

Authority: T.C.A. ยงยง 4-5-202, 4-5-209, 68-l-1001 et seq., 68-1-1002, 68-1-1003(a) and 68-1-1004.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.